|1.||Horrobin, D F: 2 articles (11/2002 - 07/2001)|
|2.||Chaudhuri, K R: 2 articles (09/2002 - 07/2001)|
|3.||Levkovitz, Yeciel: 1 article (04/2011)|
|4.||Tedeschini, Enrico: 1 article (04/2011)|
|5.||Papakostas, George I: 1 article (04/2011)|
|6.||Allawi, J: 1 article (11/2002)|
|7.||Loder, C: 1 article (11/2002)|
|8.||Wade, D T: 1 article (09/2002)|
|9.||Davidson, D L W: 1 article (09/2002)|
|10.||Young, C A: 1 article (09/2002)|
07/03/2001 - "As part of a large, randomized placebo-controlled trial of inpatients with multiple sclerosis (MS), a subsample of 15 underwent cerebral MRI at baseline and 6-months (eight on lofepramine and l-phenylalanine; seven on placebo). "
07/03/2001 - "MRI changes in multiple sclerosis following treatment with lofepramine and L-phenylalanine."
11/01/2002 - "In a randomized, placebo-controlled double-blind trial a combination of lofepramine, phenylalanine and vitamin B(12) was found to be effective in relieving the symptoms of multiple sclerosis (MS). "
09/01/2002 - "A randomised placebo controlled exploratory study of vitamin B-12, lofepramine, and L-phenylalanine (the "Cari Loder regime") in the treatment of multiple sclerosis."
11/01/2002 - "Treatment of multiple sclerosis with lofepramine, L-phenylalanine and vitamin B(12): mechanism of action and clinical importance: roles of the locus coeruleus and central noradrenergic systems."
|2.||Depressive Disorder (Melancholia)
08/01/1979 - "However, patients with endogenous depression responded significantly more rapidly to lofepramine as measured by Visual Analogue Scales and showed a significantly greater degree of clinical improvement after 4 weeks' treatment, as measured by Global Assessment. "
09/01/1978 - "Though not statistically significant, lofepramine seems to be better for neurotic depression and patients sensitive to anticholinergic side-effects."
09/01/1978 - "An open pilot study on 30 in-patients with endogenous depression showed a clear-cut circadian fluctuation of the therapeutical effect of single doses of lofepramine administered at three different times of the day (8 a.m., and 12 p.m.). "
01/01/1979 - "A double-blind trial was undertaken to compare the antidepressant efficacy and the side effects of Lofepramine with those of Amitriptyline in the treatment of endogenous depression. "
01/01/1979 - "A double-blind trial with amitriptyline and lofepramine in the treatment of endogenous depression."
07/01/1979 - "Prediction of lofepramine-response in depression based on response to partial sleep deprivation."
07/01/1979 - "The improvement of depression after partial sleep deprivation in the second half of the night (sd) is tested for its predictory power for the therapeutical efficacy of pharmacotherapy with lofepramine. "
|4.||Panic Disorder (Panic Attack)
05/01/1992 - "I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial."
10/01/1992 - "Sixty six patients with panic disorders, fulfilling the DSM III criteria for panic attack, together with a group of age and sex matched controls, were studied for changes in their peripheral noradrenergic and serotonergic status before treatment and during six months treatment with either clomipramine or lofepramine. "
05/01/1992 - "Among 79 volunteer, unpaid, family doctor-referred psychiatric out patients with DSM III-R panic disorder, with and without agoraphobia, 66 completed a six week placebo-controlled trial of lofepramine versus clomipramine and 57 survivors were followed up for 6 months. "
|2.||Vitamin B 12 (Cyanocobalamin)
|9.||Tricyclic Antidepressive Agents (Tricyclic Antidepressants)
|1.||Drug Therapy (Chemotherapy)